Triamcinolone 40 mg/mL 2 mL Single-Dose Vial for Injection — Class II drug recall D-0518-2017
Terminated recall by Isomeric Pharmacy Solution, LLC, reported 2017-03-22, distributed nationwide. CGMP Deviations
| Recall number | D-0518-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Isomeric Pharmacy Solution, LLC, Salt Lake City, UT, United States |
| Recall initiated | 2017-03-08 |
| Classified | 2017-03-13 |
| Reported by FDA | 2017-03-22 |
| Terminated | 2017-05-25 |
| Distributed | Nationwide (US) |
| Quantity | 6,999 single |
| Reason classes | cgmp |
| NDC | 70285-1920-01 |
| Lot numbers | 08016, 08018, 08023, 08026, 08033, 09004, 11014, 11031 |
| Expiration dates | 2017-03-14, 2017-03-15, 2017-03-19, 2017-03-22, 2017-03-28, 2017-04-03, 2017-06-10, 2017-06-20 |
Product
Triamcinolone 40 mg/mL 2 mL Single-Dose Vial for Injection, Preservative Free, Rx only, Compounded by Isomeric Pharmacy Solutions, Salt Lake City, UT 84109, NDC 70285-1920-1
Reason for recall
CGMP Deviations
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0518-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.